Literature DB >> 24683005

Smooth muscle cells and the formation, degeneration, and rupture of saccular intracranial aneurysm wall--a review of current pathophysiological knowledge.

Juhana Frösen1.   

Abstract

Subarachnoid hemorrhage or intracerebral hemorrhage caused by rupture of a saccular intracranial aneurysm (sIA) is often fatal and causes significant loss of productive live years in addition to significant mortality. Around 3.5 % of the middle aged otherwise healthy population carries unruptured sIAs. Many sIAs never rupture, and since their prophylactic treatment is associated with risks of morbidity and even mortality, it is paramount to elucidate the biology that leads to sIA rupture in order be able to identify rupture-prone sIAs and to improve current therapies. Smooth muscle cells (SMCs) play a critical role both in the formation of sIAs, as well as in the repair and adaptation of the sIA wall to hemodynamic and proteolytic stress to which it is subjected. Loss of mural SMCs is characteristic to ruptured sIA walls, and experiments in animal models suggest that this loss of mural SMCs is causative to sIA growth and eventual rupture. Genetic factors that impair the function or survival of SMCs may predispose to sIA formation. Local or systemic therapy that increases the number of functioning SMCs in the sIA wall may have a potential to reduce the risk of sIA rupture. This review discusses the mechanisms and cellular interactions that SMCs have in the pathobiology of the sIA wall.

Entities:  

Mesh:

Year:  2014        PMID: 24683005     DOI: 10.1007/s12975-014-0340-3

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  86 in total

1.  Contribution of mural and bone marrow-derived neointimal cells to thrombus organization and wall remodeling in a microsurgical murine saccular aneurysm model.

Authors:  Juhana Frösen; Johan Marjamaa; Marjukka Myllärniemi; Usama Abo-Ramadan; Riikka Tulamo; Mika Niemelä; Juha Hernesniemi; Juha Jääskeläinen
Journal:  Neurosurgery       Date:  2006-05       Impact factor: 4.654

Review 2.  Circulating smooth muscle progenitor cells in arterial remodeling.

Authors:  Jan-Marcus Daniel; Daniel G Sedding
Journal:  J Mol Cell Cardiol       Date:  2010-11-01       Impact factor: 5.000

Review 3.  In vivo experimental intracranial aneurysm models: a systematic review.

Authors:  F Bouzeghrane; O Naggara; D F Kallmes; A Berenstein; J Raymond
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-29       Impact factor: 3.825

Review 4.  Endovascular treatment of intracranial unruptured aneurysms: a systematic review of the literature on safety with emphasis on subgroup analyses.

Authors:  Olivier N Naggara; Augustin Lecler; Catherine Oppenheim; Jean-Francois Meder; Jean Raymond
Journal:  Radiology       Date:  2012-06       Impact factor: 11.105

5.  Experimental induction of cerebral aneurysms in monkeys.

Authors:  N Hashimoto; C Kim; H Kikuchi; M Kojima; Y Kang; F Hazama
Journal:  J Neurosurg       Date:  1987-12       Impact factor: 5.115

Review 6.  Safety and occlusion rates of surgical treatment of unruptured intracranial aneurysms: a systematic review and meta-analysis of the literature from 1990 to 2011.

Authors:  Marc Kotowski; Olivier Naggara; Tim E Darsaut; Suzanne Nolet; Guylaine Gevry; Evgueni Kouznetsov; Jean Raymond
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-09-25       Impact factor: 10.154

7.  Evidence for apoptosis in human intracranial aneurysms.

Authors:  A Hara; N Yoshimi; H Mori
Journal:  Neurol Res       Date:  1998-03       Impact factor: 2.448

8.  Histologic and morphologic comparison of experimental aneurysms with human intracranial aneurysms.

Authors:  T Abruzzo; G G Shengelaia; R C Dawson; D S Owens; C M Cawley; M B Gravanis
Journal:  AJNR Am J Neuroradiol       Date:  1998-08       Impact factor: 3.825

9.  International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion.

Authors:  Andrew J Molyneux; Richard S C Kerr; Ly-Mee Yu; Mike Clarke; Mary Sneade; Julia A Yarnold; Peter Sandercock
Journal:  Lancet       Date:  2005 Sep 3-9       Impact factor: 79.321

10.  Lipid accumulation, lipid oxidation, and low plasma levels of acquired antibodies against oxidized lipids associate with degeneration and rupture of the intracranial aneurysm wall.

Authors:  Juhana Frösen; Riikka Tulamo; Tommi Heikura; Sini Sammalkorpi; Mika Niemelä; Juha Hernesniemi; Anna-Liisa Levonen; Sohvi Hörkkö; Seppo Ylä-Herttuala
Journal:  Acta Neuropathol Commun       Date:  2013-10-28       Impact factor: 7.801

View more
  36 in total

Review 1.  Flow-induced, inflammation-mediated arterial wall remodeling in the formation and progression of intracranial aneurysms.

Authors:  Juhana Frösen; Juan Cebral; Anne M Robertson; Tomohiro Aoki
Journal:  Neurosurg Focus       Date:  2019-07-01       Impact factor: 4.047

2.  Regional Mapping of Flow and Wall Characteristics of Intracranial Aneurysms.

Authors:  Juan R Cebral; Xinjie Duan; Piyusha S Gade; Bong Jae Chung; Fernando Mut; Khaled Aziz; Anne M Robertson
Journal:  Ann Biomed Eng       Date:  2016-06-27       Impact factor: 3.934

Review 3.  From bench to bedside: utility of the rabbit elastase aneurysm model in preclinical studies of intracranial aneurysm treatment.

Authors:  Waleed Brinjikji; Yong H Ding; David F Kallmes; Ramanathan Kadirvel
Journal:  J Neurointerv Surg       Date:  2015-04-22       Impact factor: 5.836

4.  Rare Coding Variants in ANGPTL6 Are Associated with Familial Forms of Intracranial Aneurysm.

Authors:  Romain Bourcier; Solena Le Scouarnec; Stéphanie Bonnaud; Matilde Karakachoff; Emmanuelle Bourcereau; Sandrine Heurtebise-Chrétien; Céline Menguy; Christian Dina; Floriane Simonet; Alexis Moles; Cédric Lenoble; Pierre Lindenbaum; Stéphanie Chatel; Bertrand Isidor; Emmanuelle Génin; Jean-François Deleuze; Jean-Jacques Schott; Hervé Le Marec; Gervaise Loirand; Hubert Desal; Richard Redon
Journal:  Am J Hum Genet       Date:  2018-01-04       Impact factor: 11.025

5.  Influence of TGF-β1 expression in endothelial cells on smooth muscle cell phenotypes and MMP production under shear stress in a co-culture model.

Authors:  Xiaobo Han; Naoya Sakamoto; Noriko Tomita; Hui Meng; Masaaki Sato; Makoto Ohta
Journal:  Cytotechnology       Date:  2019-02-01       Impact factor: 2.058

6.  Demographic and morphological characteristics associated with rupture status of anterior communicating artery aneurysms.

Authors:  Xiangke Ma; Yang Yang; Dongtao Liu; Yiming Zhou; Weihua Jia
Journal:  Neurosurg Rev       Date:  2019-01-31       Impact factor: 3.042

7.  Endovascular Biopsy: In Vivo Cerebral Aneurysm Endothelial Cell Sampling and Gene Expression Analysis.

Authors:  Daniel L Cooke; David B McCoy; Van V Halbach; Steven W Hetts; Matthew R Amans; Christopher F Dowd; Randall T Higashida; Devon Lawson; Jeffrey Nelson; Chih-Yang Wang; Helen Kim; Zena Werb; Charles McCulloch; Tomoki Hashimoto; Hua Su; Zhengda Sun
Journal:  Transl Stroke Res       Date:  2017-09-13       Impact factor: 6.829

8.  Secreted Protein Acidic and Rich in Cysteine Modulates Molecular Arterial Homeostasis of Human Arterial Smooth Muscle Cells In Vitro.

Authors:  Geng-Fan Ye; Shao-Wei Zhu; Shu-Gan Zhu; Feng Li; Yun-Yan Wang
Journal:  J Mol Neurosci       Date:  2016-08-25       Impact factor: 3.444

9.  Interleukin Enhancer Binding Factor 2 Regulates Cell Viability and Apoptosis of Human Brain Vascular Smooth Muscle Cells.

Authors:  Liang Wei; Cheng Yang; Guangxue Wang; Keqin Li; Yanfei Zhang; Hongxin Guan; Zhiyang Sun; Chunlong Zhong
Journal:  J Mol Neurosci       Date:  2020-08-04       Impact factor: 3.444

10.  Hemodynamic alterations after stent implantation in 15 cases of intracranial aneurysm.

Authors:  Chao Wang; Zhongbin Tian; Jian Liu; Linkai Jing; Nikhil Paliwal; Shengzhang Wang; Ying Zhang; Jianping Xiang; Adnan H Siddiqui; Hui Meng; Xinjian Yang
Journal:  Acta Neurochir (Wien)       Date:  2016-01-08       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.